Cardiovascular Diseases Clinical Trial
To test a practical, theory-based intervention to achieve long-term behavior change for postmenopausal women with Type 2 diabetes at high risk for developing coronary heart disease (CHD).
BACKGROUND:
The overall goal of this study was to test a practical, theory-based intervention to achieve
long-term behavior change for women with Type 2 diabetes at high risk for developing
coronary heart disease (CHD). Epidemiological and clinical studies suggest that diabetes is
associated with increased risk for CHD that is greater in women than in men. CHD is a major
cause of death and functional limitations in women, but the vast majority of CHD studies
have primarily involved middle-aged men. There is convincing research evidence that healthy
lifestyle behaviors, including low-fat diet, physical activity, stress management, smoking
cessation, and social support, can reduce CHD risk
The study was initiated in response to a Request for Applications released in October 1997
by the National Institutes of Health Office of the Director on "Innovative Approaches to
Disease Prevention Through Behavior Change."
DESIGN NARRATIVE:
The study was a randomized trial to compare short-term (6-month) outcomes in women receiving
usual care compared to a modified Ornish-type comprehensive lifestyle management (CLM)
intervention. Participants (N = 279) were randomized to usual care (UC) or Mediterranean
Lifestyle Program, a lifestyle change intervention aimed at the behavioral risk factors
(eating patterns, physical activity, stress management, and social support) affecting risk
for CHD in postmenopausal women with type 2 diabetes. After 6 months, women in the CLM
condition were randomized to one of two approaches for providing support either lay-led
group support or personalized computer-based support - to evaluate these strategies in
enhancing longer-term maintenance of effects. Outcomes included multiple CHD lifestyle
behaviors (e.g., dietary intake, exercise levels, stress management, smoking cessation),
physiological risk factors associated with CHD (e.g., serum lipids, hypertension, weight,
vascular reactivity), HbA1c (glycated hemoglobin, a measure of diabetes), and quality of
life (e.g., depression, functioning).
;
Allocation: Randomized, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|